Samsara Bio Capital, LLC Scholar Rock Holding Corp Transaction History
Samsara Bio Capital, LLC
- $326 Million
- Q4 2024
A detailed history of Samsara Bio Capital, LLC transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 5,612,896 shares of SRRK stock, worth $203 Million. This represents 74.36% of its overall portfolio holdings.
Number of Shares
5,612,896
Previous 6,788,609
17.32%
Holding current value
$203 Million
Previous $54.4 Million
346.13%
% of portfolio
74.36%
Previous 31.52%
Shares
5 transactions
Others Institutions Holding SRRK
# of Institutions
257Shares Held
88.6MCall Options Held
1.82MPut Options Held
1.17M-
Price T Rowe Associates Inc Baltimore, MD9.28MShares$336 Million0.05% of portfolio
-
Siren, L.L.C. New York, NY9.25MShares$334 Million17.66% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$205 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.74MShares$171 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.55MShares$164 Million15.38% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $1.87B
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...